The World Health Organization has announced the launch of a new project aiming to accelerate the development and accessibility of bird flu vaccine for manufacturers in low- and middle-income countries.
The Argentinian manufacturer Sinergium Biotech will lead the effort to develop human avian influenza (H5N1) messenger RNA (mRNA) vaccine candidates, leveraging the WHO and the Medicines Patent Pool mRNA Technology Transfer Program.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
by Joji Xavier
For comments and feedback: contact editorial@rttnews.com